Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D.

Episode 3: Hear this clinical panel share a quick overview of the patient support resources available to help patients with T2D get off to a successful start with this GLP-1 RA treatment option.

Episode 3: Hear this clinical panel share a quick overview of the patient support resources available to help patients with T2D get off to a successful start with this GLP-1 RA treatment option. This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic. This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.

Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D.

Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D. This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.